VCID: 283169
Profile
Corporate information
Official name
Mylan Inc
Registration country
Company type
Global pharmaceutical company.Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world.
Funding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
TPG Growth LLC | The middle market and growth equity investment platform of TPG. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
TPG Capital LP Private equity firm |
+1 (415) 743-1500 |
N/A |
|
|
TPG Growth LLC The middle market and growth equity investment platform of TPG. |
+1 (650) 289-5800 |
N/A |
|
Viatris |
Acquisition |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Zyomyx Inc Developer of protein chips. |
United States | 30 Jun 2013 | Venture Initial investment. Led the investment round. Active |